Tag:Biopharmaceutical Industry

Professor Lietzan Speaks on Panel at Supreme Court IP Review

November 6th, 2017

Professor Erika Lietzan recently served as a panelist at the Supreme Court IP Review held at the Chicago-Kent College of Law. She discussed Sandoz, Inc. v. Amgen. Inc., a case decided by the Supreme Court last June.

Read More

Thomas Edison Innovation Fellowship Awarded to Professor Lietzan

November 30th, 2015

Professor Erika Lietzan was recently awarded a Thomas Edison Innovation Fellowship for 2016-17 from the Center for the Protection of Intellectual Property at George Mason University School of Law. The fellowship is a one-year program that will bring

Read More

Biopharmaceutical Data Exclusivity Topic of Presentation by Professor Lietzan

May 28th, 2015

Professor Erika Lietzan recently presented her research on biopharmaceutical data exclusivity to a group of scholars at the second annual BioIP New Scholars Workshop at Boston University. According to the website, the workshop gives three new scholars

Read More

Professor Lietzan’s Presentation on Biosimilar Biological Products Featured by The Pink Sheet

October 15th, 2014

Professor Erika Lietzan’s presentation at an annual meeting of the Drug Information Association was covered by The Pink Sheet, a publication that reports on “regulatory, legislative, legal and business developments” in the biopharmaceutical industry. Professor Lietzan was the only law

Read More